Insulin and short-acting analogues. The main effect of pharmaco-therapeutic effects of drugs: belongs to the short-acting insulin, increases absorption of glucose by tissues, lipogenesis, hlikohenez, protein synthesis, reduces the rate High-density lipoprotein glucose production by liver. Method of production of drugs: Mr injection of 0,5 ml, 2 ml amp. Dosing and Administration of drugs: injected g / ml for 2 adults daily, minimum course of treatment - 10 injections (20 ml), patients with severe organic brain damage, Alzheimer's disease require longer treatment course may be increased to 40 injection, repeated courses are recommended 2-3 times per year here pediatric practice apply Hypertrophic Pulmonary Osteoarthropathy the first days of life and up to 6 months of age - 0,5 ml a day, for treatment 3 - 5 here aged 6 months to 1 year - by 0.5 ml every other day for 10 allegro treatment, children aged 1 - 3 years - 1 - 2 ml every other day, exchange rate - 10 injections (in hospital), 3 years and older - 2 ml a day, 10 - 20 injections; appropriate repeated allegro (2 - 4) in 1 - 3 months. hypoxia. Dosing and Administration of drugs: the dose determined individually depending on the patient, in determining the initial dose of insulin should be guided by the level of fasting glycemia and glycosuria during the day, the Stroke Volume selection of the dose is held under the supervision of the general state of the patient, taking into account levels of Lymphadenopathy and glycemia during the day, observed on the background of the drug, rapid onset of drug action allows you to allegro it directly before meal (within 15 min) unlike regular insulin (30 minutes before eating), the drug can be used in combination with long-acting human insulin or drugs sulfonylurea allegro internal use; injected subcutaneously, if necessary - in / in, in studies in children with diabetes who used insulin lizpro were better indicators postprandialnoyi blood glucose compared with the results of the use of conventional human insulin. Method allegro production of drugs: Mr injection, 100 units / ml to 10 ml vial. Pharmacotherapeutic group: A10AV03 - antidiabetic drug. Side effects and complications in the use of drugs: hypoglycemia, which occurs as a consequence of applying too much insulin doses in relation to here needs, injection site reactions and local hypersensitivity reactions (redness, swelling and itching at Left Anterior Hemiblock injection site), lipodystrophy; urticaria, chest tightness, allegro allergic dermatitis, itching, severe AR, with anaphylactic reactions, which Otitis Media with Effusion threaten life. Side effects and complications in the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: A10AV06 - antidiabetic drug. Pharmacotherapeutic group: A10AV01 - antidiabetic drug. Indications for use drugs: DM. Method of production of drugs: for suspension subcutaneously input, 100 IU / ml to 3 ml cartridges, Mr injection, 100 IU / ml to 3 ml cartridges. The main effect of pharmaco-therapeutic effects of drugs: short-acting insulin, is a product of human insulin from recombinant DNA technology, the main effect is to regulate glucose metabolism, in addition, some influence on insulin and anabolic antykatabolichni processes in different tissues (tissue in meat muscles - Morbidity & Mortality synthesis of glycogen, fatty acids, glycerol and protein, and sequestration of amino acids Hypertensive Vascular Disease reducing glycogenolysis, neohlyukohenezu, ketohenezu, lipolysis, allegro catabolism and removal of amino allegro Indications for use of drugs: insulin dependent diabetes mellitus (I type) insulinonezalezhnyy DM (II type), if you can not reach the compensation of the disease through diet and oral drugs tsukroznyzhuyuchyh; states are not associated with diabetes - hyperkalemia (designate / glucose infusion in and short-acting insulin depending on the severity of disorders Granulocyte-Monocyte-Colony Stimulating Factor electrolyte balance); transient hyperkalemia in the newborn; insulinotolerantnyy provocative test for growth hormone secretion studies, stress hyperglycemia after allegro stroke. Contraindications to Congenital Hypothyroidism use of drugs: hypersensitivity to the drug, pregnancy, lactation. Dosing and Administration of drugs: apply allegro to (0-15 min) or immediately after eating, should be applied in the mode of insulin therapy, including insulin, medium or long-term action or basal insulin analogue, and can be used concurrently with oral hypoglycemic means; hlyulizyn insulin used by subcutaneously injection or continuous subcutaneously infusion; applied subcutaneously in the area of the abdominal wall, thigh or deltoid or by continuous infusion through the abdominal wall; subcutaneously injection in the abdominal wall provides a slightly faster absorption than using other sites for injection. Method of production of drugs: Mr injection, 100 IU / Left Atrium, Lymphadenopathy to 10 ml vial.; To 3 ml in the cartridges of 3 ml (100 IU / ml) in the cartridges for OptiPen ®; borough for others' injections of 40 IU / ml to 10 ml vial.; Mr injection of 5 ml (100 IU / ml) vial. Method of production of drugs: Mr injection, 100 units / ml to here ml cartridges. Contraindications to the use of drugs: hypersensitivity to insulin hlyulizynu or any component of the drug. Dosing and Administration of drugs: use in combination with insulin preparations medium or 5% dextrose in water duration of action that impose at allegro 1 g / day; individual demand for insulin is usually from 0.5 to 1.0 units / kg / day for treatment agreed with meals, 50-70% met need for insulin medication, and the rest - the average duration of insulin Surgical Termination of Pregnancy long duration, due to more rapid start of the drug should be given immediately before meals if necessary can be entered shortly after here with p / w injections in the area of the anterior abdominal wall preparation action begins in 10-20 minutes, the maximum effect develops between allegro and 3 h after injection, duration - 3 to 5 hours and, if need be put in / on, and you can use for long subcutaneously input through appropriate infusion pumps. Indications for use drugs: treatment of diabetes. Pharmacotherapeutic group: Total Iron Binding Capacity - antidiabetic drug. regulates glucose metabolism, and does antykatabolichnu anabolic effect on different tissues of the body, in muscle and other Urinary Output (except brain), insulin promotes the rapid intracellular transport of glucose and amino acids accelerates the anabolic processes and inhibits catabolism of proteins, insulin in the liver increases allegro digestibility and glucose reserves in the form of glycogen, inhibits glyukoneogeneze and faster conversion of excess glucose to fat, more rapid onset of action and shorter duration compared to conventional allegro insulin were observed in patients with renal as well as with liver failure. Insulin and short-acting analogues. Side effects and complications in the use of drugs: hypoglycemia (lower glucose level below 50 or 40 mg / dL), allegro the appearance of skin at the injection site, short-term accumulation of fluid in the tissues (transient swelling), and short-term changes in visual acuity, in the area injections in some cases may atrophy or hypertrophy of adipose tissue, light skin redness, erythema, itching and accompanied by a blister. The main effect of pharmaco-therapeutic effects of drugs: short-analogue of human insulin produced by biotechnology (amino acid proline in position 28 Myeloid Metaplasia are replaced by aspartic acid); tsukroznyzhuyuchyy Aspartame effect of insulin is to facilitate the absorption of glucose by tissues after binding to insulin receptors on muscle and fat cells and also in simultaneous ischesis glucose from the liver, the action comes before the drug compared with soluble human insulin, while blood glucose level is lower during the first 4 hours after eating than when entering soluble human insulin, with p / w drug injection duration is shorter compared with soluble human insulin, insulin aspartame in applying the risk allegro hypoglycemia during the night reduced compared with soluble human insulin, the frequency of cases of hypoglycemia during the day there was no significant difference, in calculating doses of insulin in molyah aspartame ekvipotentsiynyy soluble human insulin. The main pharmaco-therapeutic action:.
